23PDesign of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients. (13th May 2019) - Haugen, M H; Lingjærde, O C; Garred, Ø; Hedenfalk, I; Loman, N; Mills, G; Borresen-Dale, A-L; Naume, B; Mælandsmo, G M; Engebråten, O